284 related articles for article (PubMed ID: 21827411)
21. Competitive substrates for P-glycoprotein and organic anion protein transporters differentially reduce blood organ transport of fentanyl and loperamide: pharmacokinetics and pharmacodynamics in Sprague-Dawley rats.
Elkiweri IA; Zhang YL; Christians U; Ng KY; Tissot van Patot MC; Henthorn TK
Anesth Analg; 2009 Jan; 108(1):149-59. PubMed ID: 19095843
[TBL] [Abstract][Full Text] [Related]
22. ATP-binding cassette (ABC) drug transporters in the developing blood-brain barrier: role in fetal brain protection.
Eng ME; Imperio GE; Bloise E; Matthews SG
Cell Mol Life Sci; 2022 Jul; 79(8):415. PubMed ID: 35821142
[TBL] [Abstract][Full Text] [Related]
23. Transport of selected PET radiotracers by human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2): an in vitro screening.
Tournier N; Valette H; Peyronneau MA; Saba W; Goutal S; Kuhnast B; Dollé F; Scherrmann JM; Cisternino S; Bottlaender M
J Nucl Med; 2011 Mar; 52(3):415-23. PubMed ID: 21321274
[TBL] [Abstract][Full Text] [Related]
24. Interaction of angiotensin receptor type 1 blockers with ATP-binding cassette transporters.
Weiss J; Sauer A; Divac N; Herzog M; Schwedhelm E; Böger RH; Haefeli WE; Benndorf RA
Biopharm Drug Dispos; 2010 Mar; 31(2-3):150-61. PubMed ID: 20222053
[TBL] [Abstract][Full Text] [Related]
25. Blood-brain barrier active efflux transporters: ATP-binding cassette gene family.
Löscher W; Potschka H
NeuroRx; 2005 Jan; 2(1):86-98. PubMed ID: 15717060
[TBL] [Abstract][Full Text] [Related]
26. Regulation of ABC transporters blood-brain barrier: the good, the bad, and the ugly.
Miller DS
Adv Cancer Res; 2015; 125():43-70. PubMed ID: 25640266
[TBL] [Abstract][Full Text] [Related]
27. Interplay of drug metabolizing CYP450 enzymes and ABC transporters in the blood-brain barrier.
Decleves X; Jacob A; Yousif S; Shawahna R; Potin S; Scherrmann JM
Curr Drug Metab; 2011 Oct; 12(8):732-41. PubMed ID: 21623707
[TBL] [Abstract][Full Text] [Related]
28. Double-transduced MDCKII cells to study human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) interplay in drug transport across the blood-brain barrier.
Poller B; Wagenaar E; Tang SC; Schinkel AH
Mol Pharm; 2011 Apr; 8(2):571-82. PubMed ID: 21309545
[TBL] [Abstract][Full Text] [Related]
29. Investigation of efflux transport of dehydroepiandrosterone sulfate and mitoxantrone at the mouse blood-brain barrier: a minor role of breast cancer resistance protein.
Lee YJ; Kusuhara H; Jonker JW; Schinkel AH; Sugiyama Y
J Pharmacol Exp Ther; 2005 Jan; 312(1):44-52. PubMed ID: 15448171
[TBL] [Abstract][Full Text] [Related]
30. Regulation of ABC membrane transporters in glial cells: relevance to the pharmacotherapy of brain HIV-1 infection.
Ronaldson PT; Persidsky Y; Bendayan R
Glia; 2008 Dec; 56(16):1711-35. PubMed ID: 18649402
[TBL] [Abstract][Full Text] [Related]
31. ABC transporter regulation by signaling at the blood-brain barrier: relevance to pharmacology.
Miller DS
Adv Pharmacol; 2014; 71():1-24. PubMed ID: 25307212
[TBL] [Abstract][Full Text] [Related]
32. Quantitative evaluation of the impact of active efflux by p-glycoprotein and breast cancer resistance protein at the blood-brain barrier on the predictability of the unbound concentrations of drugs in the brain using cerebrospinal fluid concentration as a surrogate.
Kodaira H; Kusuhara H; Fujita T; Ushiki J; Fuse E; Sugiyama Y
J Pharmacol Exp Ther; 2011 Dec; 339(3):935-44. PubMed ID: 21934030
[TBL] [Abstract][Full Text] [Related]
33. Restricting CNS penetration of drugs to minimise adverse events: role of drug transporters.
Bagal S; Bungay P
Drug Discov Today Technol; 2014 Jun; 12():e79-85. PubMed ID: 25027378
[TBL] [Abstract][Full Text] [Related]
34. Use of plasma and brain unbound fractions to assess the extent of brain distribution of 34 drugs: comparison of unbound concentration ratios to in vivo p-glycoprotein efflux ratios.
Kalvass JC; Maurer TS; Pollack GM
Drug Metab Dispos; 2007 Apr; 35(4):660-6. PubMed ID: 17237155
[TBL] [Abstract][Full Text] [Related]
35. ATP-binding cassette transporters in primary central nervous system lymphoma: decreased expression of MDR1 P-glycoprotein and breast cancer resistance protein in tumor capillary endothelial cells.
Sakata S; Fujiwara M; Ohtsuka K; Kamma H; Nagane M; Sakamoto A; Fujioka Y
Oncol Rep; 2011 Feb; 25(2):333-9. PubMed ID: 21165575
[TBL] [Abstract][Full Text] [Related]
36. P-glycoprotein modulates morphine uptake into the CNS: a role for the non-steroidal anti-inflammatory drug diclofenac.
Sanchez-Covarrubias L; Slosky LM; Thompson BJ; Zhang Y; Laracuente ML; DeMarco KM; Ronaldson PT; Davis TP
PLoS One; 2014; 9(2):e88516. PubMed ID: 24520393
[TBL] [Abstract][Full Text] [Related]
37. Constitutive androstane receptor upregulates Abcb1 and Abcg2 at the blood-brain barrier after CITCO activation.
Lemmen J; Tozakidis IE; Bele P; Galla HJ
Brain Res; 2013 Mar; 1501():68-80. PubMed ID: 23340159
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics and pharmacodynamics of seven opioids in P-glycoprotein-competent mice: assessment of unbound brain EC50,u and correlation of in vitro, preclinical, and clinical data.
Kalvass JC; Olson ER; Cassidy MP; Selley DE; Pollack GM
J Pharmacol Exp Ther; 2007 Oct; 323(1):346-55. PubMed ID: 17646430
[TBL] [Abstract][Full Text] [Related]
39. ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier.
Dauchy S; Dutheil F; Weaver RJ; Chassoux F; Daumas-Duport C; Couraud PO; Scherrmann JM; De Waziers I; Declèves X
J Neurochem; 2008 Dec; 107(6):1518-28. PubMed ID: 19094056
[TBL] [Abstract][Full Text] [Related]
40. ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy.
Lazarowski A; Czornyj L; Lubienieki F; Girardi E; Vazquez S; D'Giano C
Epilepsia; 2007; 48 Suppl 5():140-9. PubMed ID: 17910594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]